The timing of solid introduction in an 'obesogenic' environment: a narrative review of the evidence and

Lynne Daniels1, Kimberley M Mallan1, Alison Fildes1,2

  • 1School of Exercise and Nutrition Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology.

Insights

Introducing solids before 4 months may increase childhood obesity risk. However, evidence does not strongly support adverse outcomes for introducing solids between 4-6 months versus 6 months.

Area of Science:

  • Pediatric Nutrition
  • Public Health
  • Obesity Research

Background:

  • Infant feeding practices significantly influence long-term health outcomes.
  • Current guidelines recommend exclusive breastfeeding for six months, but many infants in developed countries receive solids earlier.
  • The association between the timing of solid food introduction and obesity risk requires further investigation.

Purpose of the Study:

  • To review existing evidence on the relationship between the timing of solid food introduction and obesity risk in infants.
  • To assess the quality of studies examining early versus later introduction of complementary foods.

Main Methods:

  • Systematic review of studies published between 1990 and March 2013.
  • Included papers focused on weight status or obesity prevalence outcomes in healthy term infants.
  • Predominantly cohort studies were analyzed, with attention to methodological limitations.

Main Results:

  • Twenty-six relevant papers were identified, with ten reporting a positive association between early solids and obesity risk.
  • Only two large, high-quality studies found a positive association, both examining introduction before 4 months.
  • No significant protective effect was found for introducing solids at 4-6 months compared to 6 months in four high-quality studies.

Conclusions:

  • Introducing solids before 4 months of age may be linked to a higher risk of childhood obesity.
  • There is limited evidence suggesting adverse weight outcomes from introducing solids between 4-6 months compared to 6 months.
  • Further high-quality research is needed to establish optimal complementary feeding guidelines.
Abstract

Related Concept Videos

Fats as Energy Storage Molecules01:06

Fats as Energy Storage Molecules

Triglycerides are a form of long-term energy storage molecules. They are made of glycerol and three fatty acids. To obtain energy from fat, triglycerides must first be broken down by hydrolysis into their two principal components, fatty acids and glycerol. This process, called lipolysis, takes place in the cytoplasm. The resulting fatty acids are oxidized by β-oxidation into acetyl-CoA, which is used by the Krebs cycle. The glycerol that is released from triglycerides after lipolysis directly...
Observational Studies01:11

Observational Studies

Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One example of...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...